Piperazine

Piperazine

SCHEMBL4405486

C1CNCCN1.CCC(=O)Cc1ccccc1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.47
CES1 P23141 1/20 0.47
AKR1B1 P15121 1/20 0.47
HSD11B1 P28845 2/20 0.46
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
KMT2A Q03164 2/20 0.43
ALDH1A1 P00352 3/20 0.42
GLA P06280 1/20 0.42
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MEN1 O00255 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
KDM4E B2RXH2 1/20 0.41
TP53 P04637 1/20 0.41
TSHR P16473 2/20 0.41
CTSD P07339 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL43241 0.88 CES1 (0.58) CES2CES1AKR1B1HSD11B1TDP1
Benzene SCHEMBL27614820 0.88 CES1 (0.58) CES2CES1AKR1B1HSD11B1TDP1
Methane SCHEMBL2442457 0.86 CES1 (0.56) CES2CES1AKR1B1HSD11B1TDP1
Water SCHEMBL27427566 0.86 CES1 (0.56) CES2CES1AKR1B1HSD11B1TDP1
SCHEMBL10999568 0.86 CES1 (0.56) CES2CES1AKR1B1HSD11B1TDP1
Benzene SCHEMBL27747096 0.86 CES1 (0.56) CES2CES1AKR1B1HSD11B1TDP1
Butane SCHEMBL11691843 0.84 CES1 (0.54) CES2CES1AKR1B1HSD11B1TDP1
Morpholine SCHEMBL28168698 0.83 MAPT (0.42) CES2CES1AKR1B1HSD11B1TDP1
Urea SCHEMBL6171504 0.82 CES1 (0.52) CES2CES1AKR1B1HSD11B1TDP1
Dimethylamine SCHEMBL3684568 0.82 CES1 (0.52) CES2CES1AKR1B1HSD11B1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117479932-A Pyrazolone compounds for degenerative retinal diseases 弗洛内克斯特(股份)责任有限公司 2024-01-30 CN claimed
CN-117479932-A Pyrazolone compounds for degenerative retinal diseases 弗洛内克斯特(股份)责任有限公司 2024-01-30 CN disclosed
EP-2138561-A1 Stable aqueous surfactant compositions Lubrizol Advanced Materials, Inc. (US) 2009-12-30 EP disclosed
EP-1272159-B1 STABLE AQUEOUS SURFACTANT COMPOSITIONS LUBRIZOL ADVANCED MAT INC (US) 2009-08-19 EP disclosed
US-7217752-B2 Stable aqueous surfactant compositions NOVEON, INC. (US) 2007-05-15 US disclosed
US-20050158268-A1 Stable aqueous surfactant compositions NOVEON IP HOLDING CORP (US) 2005-07-21 US disclosed
US-6897253-B2 Stable aqueous surfactant compositions NOVEON IP HOLDINGS CORP. (US) 2005-05-24 US disclosed
CN-1195498-C Directly compressed solid dosage particles NOVEON IP HOLDINGS CORP (US) 2005-04-06 CN disclosed
US-20040087668-A1 Mixture containing alkali-soluble crosslinked poly(meth)acrylic acid; adding base to reduce pH; mixture containing cationic hair dye; storage stability NOVEON IP HOLDINGS CORP. 2004-05-06 US disclosed
CN-1471545-A Rheology modifying copolymer composition ŵ�ֶ�IP�عɹ�˾ 2004-01-28 CN disclosed
EP-1276466-B1 DIRECTLY COMPRESSED SOLID DOSAGE PARTICLES NOVEON IP HOLDINGS CORP (US) 2003-12-10 EP disclosed
US-6635702-B1 Having crosslinked alkali swellable acrylate copolymer rheology modifier NOVEON IP HOLDINGS CORP. 2003-10-21 US disclosed
US-6623756-B1 Controlled release tablet containing active ingredient, slightly crosslinked swellable polymer with good flow characteristics and excipients NOVEON IP HOLDINGS CORP. 2003-09-23 US disclosed
EP-1330477-A2 RHEOLOGY MODIFYING COPOLYMER COMPOSITION Noveon IP Holdings Corp. (US) 2003-07-30 EP disclosed
CN-1426297-A Directly compressed solid dosage formulations NOVEON IP HOLDINGS CORP (US) 2003-06-25 CN disclosed
EP-1272159-A2 STABLE AQUEOUS SURFACTANT COMPOSITIONS Noveon IP Holdings Corp. (US) 2003-01-08 EP disclosed
US-6433061-B1 CROSSLINKED COPOLYMER OF UNSATURATED CARBOXYLIC ACID, HYDROPHOBIC MONOMER, AND CHAIN TRANSFER AGENT; INCREASES VISCOSITY IN SALT-CONTAINING SYSTEMS; FOR USE IN SHAMPOOS, CLEANERS, AND DRUG DELIVERY SYSTEMS NOVEON IP HOLDINGS CORP. 2002-08-13 US disclosed
WO-2002034793-A2 RHEOLOGY MODIFYING COPOLYMER COMPOSITION NOVEON IP HOLDINGS CORP. (US) 2002-05-02 WO disclosed
WO-2001076552-A2 STABLE AQUEOUS SURFACTANT COMPOSITIONS NOVEON IP HOLDINGS CORP. (US) 2001-10-18 WO disclosed